Malignant Lymphoma, Non-Hodgkin
2 clinical trials · Condition
◉ Watch Malignant Lymphoma, Non-Hodgkin
| Record | Firm | Date |
|---|---|---|
| Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis (NCT06756152) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2024-07-10 |
| Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT (NCT00482053) | Stanford University | 2006-10-01 |
Track Malignant Lymphoma, Non-Hodgkin automatically
Every clearance here is in the API, with alerts when new ones post.